http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 11 Aug 2026 08:30:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Conexeu+to+Present+at+2026+Controversies+%26+Conversations+in+Laser+%26+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902031.html <p align="left">RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ib837EJgRudHJqFCcRXKkwzuUjumkML98BS2OvtiM_Ha6hoHh7ySFc1QqjmDkmgEtIqni9PChBkCHCLcmdxJS0JQ_UeWvibBoqRdK_4cq6U=" rel="nofollow" target="_blank"><strong>Conexeu Sciences Inc.</strong></a><strong> (Nasdaq: CNXU) ("Conexeu" or the "Company"),</strong> a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, announced today that Dr. Brian Pilcher, Ph.D., Chief Medical Officer of Conexeu Sciences, will present at the <a href="https://www.globenewswire.com/Tracker?data=4FLOGyqatxYBGYeVbQguH6L3aEItXquOmgft0uyq0Ak27MyOtIu2O9_OHXoE5g-tKZW8-qiILOid_oTK8BbrXcokf0sS-G7-Auwbe8xhyGNZG0FX37qSY_CjSXcKy6fPOwfbWqXuk_VTZz-KV2EitEuRpAs7R0QO63uUNq0N5Dwad4m-FoH8FNT13pV6W94o" rel="nofollow" target="_blank">Controversies &amp; Conversations in Laser &amp; Cosmetic Surgery Symposium</a>, taking place Aug. 14–16, 2026. The meeting brings together dermatologists, facial plastic surgeons, plastic surgeons, and aesthetic medicine specialists to discuss emerging technologies, clinical challenges, and evolving treatment approaches in laser surgery, cosmetic surgery, and aesthetic medicine.</p> <p>Dr. http://www.streetinsider.com/Press+Releases/Conexeu+to+Present+at+2026+Controversies+%26+Conversations+in+Laser+%26+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902031.html Tue, 11 Aug 2026 08:30:00 -0400 CNXU http://www.streetinsider.com/Globe+Newswire/Conexeu+to+Present+at+2026+Controversies+%26+Conversations+in+Laser+%26+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902031.html <p align="left">RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=ib837EJgRudHJqFCcRXKkwzuUjumkML98BS2OvtiM_Ha6hoHh7ySFc1QqjmDkmgEtIqni9PChBkCHCLcmdxJS0JQ_UeWvibBoqRdK_4cq6U=" rel="nofollow" target="_blank"><strong>Conexeu Sciences Inc.</strong></a><strong> (Nasdaq: CNXU) ("Conexeu" or the "Company"),</strong> a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, announced today that Dr. Brian Pilcher, Ph.D., Chief Medical Officer of Conexeu Sciences, will present at the <a href="https://www.globenewswire.com/Tracker?data=4FLOGyqatxYBGYeVbQguH6L3aEItXquOmgft0uyq0Ak27MyOtIu2O9_OHXoE5g-tKZW8-qiILOid_oTK8BbrXcokf0sS-G7-Auwbe8xhyGNZG0FX37qSY_CjSXcKy6fPOwfbWqXuk_VTZz-KV2EitEuRpAs7R0QO63uUNq0N5Dwad4m-FoH8FNT13pV6W94o" rel="nofollow" target="_blank">Controversies &amp; Conversations in Laser &amp; Cosmetic Surgery Symposium</a>, taking place Aug. 14–16, 2026. The meeting brings together dermatologists, facial plastic surgeons, plastic surgeons, and aesthetic medicine specialists to discuss emerging technologies, clinical challenges, and evolving treatment approaches in laser surgery, cosmetic surgery, and aesthetic medicine.</p> <p>Dr. http://www.streetinsider.com/Globe+Newswire/Conexeu+to+Present+at+2026+Controversies+%26+Conversations+in+Laser+%26+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902031.html Tue, 11 Aug 2026 08:30:00 -0400 CNXU http://www.streetinsider.com/Press+Releases/Conexeu+to+Present+at+2026+Controversies+%26amp%3B+Conversations+in+Laser+%26amp%3B+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902079.html <p align="left">RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ib837EJgRudHJqFCcRXKkwzuUjumkML98BS2OvtiM_Ha6hoHh7ySFc1QqjmDkmgEtIqni9PChBkCHCLcmdxJS0JQ_UeWvibBoqRdK_4cq6U=" rel="nofollow" target="_blank"><strong>Conexeu Sciences Inc.</strong></a><strong> (Nasdaq: CNXU) (&quot;Conexeu&quot; or the &quot;Company&quot;),</strong> a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, announced today that Dr. Brian Pilcher, Ph.D., Chief Medical Officer of Conexeu Sciences, will present at the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4FLOGyqatxYBGYeVbQguH6L3aEItXquOmgft0uyq0Ak27MyOtIu2O9_OHXoE5g-tKZW8-qiILOid_oTK8BbrXcokf0sS-G7-Auwbe8xhyGNZG0FX37qSY_CjSXcKy6fPOwfbWqXuk_VTZz-KV2EitEuRpAs7R0QO63uUNq0N5Dwad4m-FoH8FNT13pV6W94o" rel="nofollow" target="_blank">Controversies &amp; Conversations in Laser &amp; Cosmetic Surgery Symposium</a>, taking place Aug. 14–16, 2026. The meeting brings together dermatologists, facial plastic surgeons, plastic surgeons, and aesthetic medicine specialists to discuss emerging technologies, clinical challenges, and evolving treatment approaches in laser surgery, cosmetic surgery, and aesthetic medicine.</p> http://www.streetinsider.com/Press+Releases/Conexeu+to+Present+at+2026+Controversies+%26amp%3B+Conversations+in+Laser+%26amp%3B+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902079.html Tue, 11 Aug 2026 08:30:00 -0400 CNXU http://www.streetinsider.com/Globe+Newswire/Conexeu+to+Present+at+2026+Controversies+%26amp%3B+Conversations+in+Laser+%26amp%3B+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902079.html <p align="left">RENO, Nev., Aug. 11, 2026 (GLOBE NEWSWIRE) -- <a target="_blank" href="https://www.globenewswire.com/Tracker?data=ib837EJgRudHJqFCcRXKkwzuUjumkML98BS2OvtiM_Ha6hoHh7ySFc1QqjmDkmgEtIqni9PChBkCHCLcmdxJS0JQ_UeWvibBoqRdK_4cq6U=" rel="nofollow" target="_blank"><strong>Conexeu Sciences Inc.</strong></a><strong> (Nasdaq: CNXU) (&quot;Conexeu&quot; or the &quot;Company&quot;),</strong> a preclinical-stage biotechnology company advancing an investigational tissue-restoration platform, announced today that Dr. Brian Pilcher, Ph.D., Chief Medical Officer of Conexeu Sciences, will present at the <a target="_blank" href="https://www.globenewswire.com/Tracker?data=4FLOGyqatxYBGYeVbQguH6L3aEItXquOmgft0uyq0Ak27MyOtIu2O9_OHXoE5g-tKZW8-qiILOid_oTK8BbrXcokf0sS-G7-Auwbe8xhyGNZG0FX37qSY_CjSXcKy6fPOwfbWqXuk_VTZz-KV2EitEuRpAs7R0QO63uUNq0N5Dwad4m-FoH8FNT13pV6W94o" rel="nofollow" target="_blank">Controversies &amp; Conversations in Laser &amp; Cosmetic Surgery Symposium</a>, taking place Aug. 14–16, 2026. The meeting brings together dermatologists, facial plastic surgeons, plastic surgeons, and aesthetic medicine specialists to discuss emerging technologies, clinical challenges, and evolving treatment approaches in laser surgery, cosmetic surgery, and aesthetic medicine.</p> http://www.streetinsider.com/Globe+Newswire/Conexeu+to+Present+at+2026+Controversies+%26amp%3B+Conversations+in+Laser+%26amp%3B+Cosmetic+Surgery+Symposium+on+the+Role+of+the+Extracellular+Matrix+in+Tissue+Regeneration/26902079.html Tue, 11 Aug 2026 08:30:00 -0400 CNXU http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Press+Releases/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html <p><strong>Issued on behalf of Conexeu Sciences Inc. (Nasdaq: CNXU)</strong></p><p>NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=LrF4u_nq-M6rhKWRIFzyXu_SqHTmlF2LhuF9syLwk8f08DOVrOInZfGu4xhPcOF3GuPEXiVog2j84gNMhsUSgzuPzAL58AtKcaJ1ABt3xUc=" rel="nofollow" target="_blank">American News Group</a> <strong>News Commentary</strong> - The multi-billion-dollar medical aesthetics market is built on a handful of category-defining breakthroughs. The neuromodulator category that Botox^® created. The hyaluronic-acid filler category. The biostimulator category. Each turned a novel way of treating the face into a franchise measured in billions, and the companies that own those categories, from AbbVie (NYSE: ABBV) and Johnson &amp; Johnson (NYSE: JNJ) to InMode (Nasdaq: INMD) and Anika Therapeutics (Nasdaq: ANIK), built enormous businesses around them. Now http://www.streetinsider.com/Globe+Newswire/Every+Few+Decades%2C+Aesthetics+Gets+a+New+Category.+One+Preclinical+Company+Thinks+Its+Extra+Cellular+Matrix+Platform+Could+Create+the+Next+One/26862984.html Tue, 04 Aug 2026 09:05:00 -0400 ABBV ABBV ANIK ANIK CNXU CNXU INMD INMD JNJ JNJ http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Conexeu+Sciences+Inc.++++++++++++++++/26845957.html si-local-file:///var/storage/secattach/20260731/26845957.html http://www.streetinsider.com/SEC+Filings/Form++D++++++++++Conexeu+Sciences+Inc.++++++++++++++++/26845957.html Fri, 31 Jul 2026 06:04:00 -0400 CNXU